558 related articles for article (PubMed ID: 11238591)
1. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM
J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591
[TBL] [Abstract][Full Text] [Related]
2. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer.
Chu J; Lloyd FL; Trifan OC; Knapp B; Rizzo MT
Mol Cancer Ther; 2003 Jan; 2(1):1-7. PubMed ID: 12533667
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.
Liu XH; Kirschenbaum A; Lu M; Yao S; Dosoretz A; Holland JF; Levine AC
J Biol Chem; 2002 Dec; 277(51):50081-6. PubMed ID: 12401798
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor upregulates constitutive cyclooxygenase 1 in primary bovine and human endothelial cells.
Bryant CE; Appleton I; Mitchell JA
Life Sci; 1998; 62(24):2195-201. PubMed ID: 9627078
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression.
Armesilla AL; Lorenzo E; Gómez del Arco P; Martínez-Martínez S; Alfranca A; Redondo JM
Mol Cell Biol; 1999 Mar; 19(3):2032-43. PubMed ID: 10022890
[TBL] [Abstract][Full Text] [Related]
6. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
Yao YG; Duh EJ
Biochem Biophys Res Commun; 2004 Aug; 321(3):648-56. PubMed ID: 15358155
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells.
Tamura M; Sebastian S; Gurates B; Yang S; Fang Z; Bulun SE
J Clin Endocrinol Metab; 2002 Jul; 87(7):3504-7. PubMed ID: 12107271
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
Ghosh AK; Hirasawa N; Niki H; Ohuchi K
J Pharmacol Exp Ther; 2000 Nov; 295(2):802-9. PubMed ID: 11046121
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.
Daniel TO; Liu H; Morrow JD; Crews BC; Marnett LJ
Cancer Res; 1999 Sep; 59(18):4574-7. PubMed ID: 10493510
[TBL] [Abstract][Full Text] [Related]
11. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.
Liu XH; Kirschenbaum A; Yao S; Stearns ME; Holland JF; Claffey K; Levine AC
Clin Exp Metastasis; 1999; 17(8):687-94. PubMed ID: 10919714
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
[TBL] [Abstract][Full Text] [Related]
14. NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.
Dormond O; Foletti A; Paroz C; Rüegg C
Nat Med; 2001 Sep; 7(9):1041-7. PubMed ID: 11533708
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 activity is necessary for the angiogenic properties of oncostatin M.
Pourtau J; Mirshahi F; Li H; Muraine M; Vincent L; Tedgui A; Vannier JP; Soria J; Vasse M; Soria C
FEBS Lett; 1999 Oct; 459(3):453-7. PubMed ID: 10526183
[TBL] [Abstract][Full Text] [Related]
16. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis.
Kuwano T; Nakao S; Yamamoto H; Tsuneyoshi M; Yamamoto T; Kuwano M; Ono M
FASEB J; 2004 Feb; 18(2):300-10. PubMed ID: 14769824
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 promotes prostate cancer progression.
Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
[TBL] [Abstract][Full Text] [Related]
19. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
